you are here:

Gufic Biosciences Ltd.

BSE: 509079 | NSE: GUFICBIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE742B01025 | SECTOR: Pharmaceuticals

BSE Live

Jun 22, 10:34
174.50 0.65 (0.37%)
Volume
AVERAGE VOLUME
5-Day
30,294
10-Day
46,768
30-Day
157,983
35,413
  • Prev. Close

    173.85

  • Open Price

    173.10

  • Bid Price (Qty.)

    174.50 (28)

  • Offer Price (Qty.)

    174.55 (12)

NSE Live

Jun 22, 10:34
174.45 0.70 (0.40%)
Volume
AVERAGE VOLUME
5-Day
200,479
10-Day
271,453
30-Day
1,215,388
89,488
  • Prev. Close

    173.75

  • Open Price

    175.45

  • Bid Price (Qty.)

    174.30 (54)

  • Offer Price (Qty.)

    174.45 (200)

Strengths (9)
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth
  • Good quarterly growth in the recent results
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge
  • Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Weaknesses (5)
  • Companies with growing costs YoY for long term projects
  • MFs decreased their shareholding last quarter
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Decline in Net Profit (QoQ)
  • Declining profits every quarter for the past 2 quarters
Opportunities (2)
  • Highest Recovery from 52 Week Low
  • Insiders bought stocks
Threats (2)
  • Increasing Trend in Non-Core Income
  • Stocks with high PE (PE > 40)
Note :Financial Information is based on Standalone numbers.